和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02142 和铂医药-B

交易中 11-07 11:35:46

12.670

-0.310

-2.39%

最高13.290	最低12.510	成交量205.30万
今开13.100	昨收12.980	日振幅6.01%
总市值110.30亿	流通市值110.30亿	总股本8.71亿
成交额2,605万	换手率0.24%	流通股本8.71亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02142","market":"HK","secType":"STK","nameCN":"和铂医药-B","latestPrice":12.67,"timestamp":1762486517054,"preClose":12.98,"halted":0,"volume":2053000,"delay":0,"floatShares":870560722,"shares":870560722,"eps":0.02811360508781614,"marketStatus":"交易中","change":-0.31,"latestTime":"11-07 11:35:46","open":13.1,"high":13.29,"low":12.51,"amount":26045775,"amplitude":0.060092,"askPrice":12.67,"askSize":26000,"bidPrice":12.66,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":0.7162205238646876,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1762488000000},"marketStatusCode":2,"adr":0,"listingDate":1607529600000,"exchange":"SEHK","adjPreClose":12.98,"openAndCloseTimeList":[[1762479000000,1762488000000],[1762491600000,1762502400000]],"volumeRatio":1.340399,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02142","defaultTab":"news","newsList":[{"id":"2581067759","title":"和铂医药-B(02142.HK)11月6日耗资127.8万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2581067759","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581067759?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:17","pubTimestamp":1762431423,"startTime":"0","endTime":"0","summary":"格隆汇11月6日丨和铂医药-B(02142.HK)公告，11月6日耗资127.8万港元回购10万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251106/31774077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02142","BK1574","BK1583","BK1161"],"gpt_icon":0},{"id":"2581272141","title":"和铂医药-B(02142)与UMOJA BIOPHARMA订立评估与授权协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2581272141","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581272141?lang=zh_cn&edition=full","pubTime":"2025-11-05 20:06","pubTimestamp":1762344403,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B 发布公告，本公司全资子公司诺纳生物(苏州)有限公司已与Umoja Biopharma, Inc.订立评估与授权协议(协议)，旨在将诺纳生物的HCAb Harbour Mice平台和NonaCarFxTM平台与Umoja Biopharma的VivoVecTM平台相结合，共同推进多款体内CAR-T细胞产品研发。根据协议条款，诺纳生物将有权获得首付款、潜在选择权付款，以及合作项目发现及开发相关里程碑付款。Umoja Biopharma将负责所有后续产品的开发和商业化工作。Umoja Biopharma的VivoVecTM体内基因递送技术可增强患者自身免疫系统对抗疾病的能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2581764942","title":"创新药资本调整三个月，谁在改变？","url":"https://stock-news.laohu8.com/highlight/detail?id=2581764942","media":"研发客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581764942?lang=zh_cn&edition=full","pubTime":"2025-11-05 05:00","pubTimestamp":1762290042,"startTime":"0","endTime":"0","summary":"研发客根据Choice数据统计整理可见，56家生物医药公司中，21家公司在过去三个月实现上涨，其余35家公司均出现不同程度下跌。其中，药捷安康的势头最猛，过去三个月的区间涨幅达384.32%。公司预计NDA将于今年三季度获批，不过显然尚未兑现。信达生物则在最新的公告中披露，2025年第三季度，公司产品收入为超33亿元人民币，同比增长40%。震荡调整之下管线推进速度如何过去三个月，创新药板块跌幅最大的是中国抗体，下跌49.06%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105050335a6e143cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251105050335a6e143cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1969619763.USD","LU2097828474.EUR","BK1583","09926","LU2097828714.EUR","LU2097828631.EUR","LU0502904849.HKD","LU2328871848.SGD","02142","LU2097828557.USD","BK1589","LU0455707207.USD","LU2242644610.SGD","06978","LU2488822045.USD","02617","BK1161","LU2097828805.USD","01801","BK1574"],"gpt_icon":0},{"id":"2580573361","title":"和铂医药-B(02142)11月4日斥资258.49万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2580573361","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580573361?lang=zh_cn&edition=full","pubTime":"2025-11-04 19:57","pubTimestamp":1762257421,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，于2025年11月4日斥资258.49万港元回购20万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365221.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02142","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2581711408","title":"和铂医药-B11月04日遭主力抛售131.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581711408","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581711408?lang=zh_cn&edition=full","pubTime":"2025-11-04 16:15","pubTimestamp":1762244147,"startTime":"0","endTime":"0","summary":"11月04日, 和铂医药-B股价跌6.43%，报收12.80元，成交金额5448.0万元，换手率0.48%，振幅7.02%，量比1.03。和铂医药-B今日主力资金净流出131.8万元，连续3日净流出，上一交易日主力净流出39.6万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为54.55%，平均跌幅为4.65%。该股近5个交易日下跌3.32%，主力资金累计净流入646.6万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入597.5万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511041620339752f851&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511041620339752f851&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2580293749","title":"每日卖空追踪 | 和铂医药-B 11月03日卖空量成交49.4万股，卖空比例为14.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580293749","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580293749?lang=zh_cn&edition=full","pubTime":"2025-11-03 16:30","pubTimestamp":1762158626,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间11月03日，涨1.56%，卖空量成交49.4万股，较上一交易日减少46.42%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103163327a6dd6994&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103163327a6dd6994&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02142","BK1583","BK1161"],"gpt_icon":0},{"id":"2580726845","title":"药闻｜AI“撕开”突破口 药物研如何摆脱“10年研发、10亿投入”困境？","url":"https://stock-news.laohu8.com/highlight/detail?id=2580726845","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580726845?lang=zh_cn&edition=full","pubTime":"2025-11-03 13:52","pubTimestamp":1762149172,"startTime":"0","endTime":"0","summary":"新华财经上海11月3日电（记者杜康）当传统医药行业还陷在“10年研发、10亿元投入”的“地狱难度”中时，AI以颠覆性的力量撕开了一个突破口，重新构建行业的效率边界以及能力边界。和铂医药AI战略再升级，前不久正式发布其Hu-mAtrIx人工智能平台驱动的首个全人源AIHCAb模型——全人源重链抗体（HCAb）生成和筛选模型。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202511033553394493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4543","BK1583","BK4528","BK4551","BK4585","BK4588","BK4587","BK1574","02142","AI","BK4023","BK1161"],"gpt_icon":0},{"id":"2579837014","title":"智通港股回购统计|10月31日","url":"https://stock-news.laohu8.com/highlight/detail?id=2579837014","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579837014?lang=zh_cn&edition=full","pubTime":"2025-10-31 09:10","pubTimestamp":1761873001,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为中国飞鹤，回购数量1200.00 万，回购金额5022.69 万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1363444.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06098","02598","00103","00386","01167","01681","02486","02869","BK1237","01497","02120","HK0000320223.HKD","09959","LU0320764755.SGD","01519","02299","02319","00909","02273","BK1100","LU2097828805.USD","00732","BK1619","02142","LU0128522157.USD","06186","02190","02005","02416","BK1599","LU1051769294.HKD","01373","06826","LU0106959298.USD","LU0588546209.SGD","BK1191","LU2097828474.EUR","LU1831875114.USD","LU0651946864.USD","01583","LU0307460666.USD","00418","00947","LU2097828714.EUR","LU1051768304.USD","LU2460026573.USD","06868","09890","BK1219","08128"],"gpt_icon":0},{"id":"2579116159","title":"和铂医药-B(02142)10月30日斥资133.33万港元回购10万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2579116159","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579116159?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:07","pubTimestamp":1761818870,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，该公司于2025年10月30日斥资133.33万港元回购10万股股份，每股回购价格为13.11-13.46港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","02142","BK1574","BK1161"],"gpt_icon":0},{"id":"2579165257","title":"和铂医药-B(02142.HK)涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579165257","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579165257?lang=zh_cn&edition=full","pubTime":"2025-10-30 11:26","pubTimestamp":1761794817,"startTime":"0","endTime":"0","summary":"每经AI快讯，和铂医药-B(02142.HK)涨超4%，截至发稿，涨3.29%，报13.49港元，成交额5254.08万港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510303549882522.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510303549882522.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1583","BK1574","BK1161","02142"],"gpt_icon":0},{"id":"2579216363","title":"港股异动 | 和铂医药-B(02142)涨超4% 发布首个全人源HCAb生成模型 加速新一代疗法落地","url":"https://stock-news.laohu8.com/highlight/detail?id=2579216363","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579216363?lang=zh_cn&edition=full","pubTime":"2025-10-30 10:59","pubTimestamp":1761793178,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，和铂医药-B涨超4%，截至发稿，涨3.29%，报13.49港元，成交额5254.08万港元。消息面上，据和铂医药官微消息，10月28日，“智耀和铂 汇创星辰” 和铂医药全球研发日活动于中国上海成功举办，会上，和铂医药正式发布其Hu-mAtrIx人工智能平台驱动的首个全人源AI HCAb模型——全人源重链抗体生成和筛选模型。依托AI能力与HCAb技术基石，和铂医药正加速推进新一代创新疗法的落地，并通过数据驱动的预测流程发掘尚未满足的临床需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1362556.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | 和铂医药-B(02142)涨超4% 发布首个全人源HCAb生成模型 加速新一代疗法落地","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","BK1574","02142"],"gpt_icon":0},{"id":"2578674957","title":"每日卖空追踪 | 和铂医药-B 10月28日卖空量成交22.2万股，卖空比例为9.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578674957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578674957?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:30","pubTimestamp":1761640227,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间10月28日，跌1.36%，卖空量成交22.2万股，较上一交易日减少77.32%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028163535a4794cd3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251028163535a4794cd3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02142","BK1583","BK1574"],"gpt_icon":0},{"id":"2578987562","title":"构建多元化合作模式 和铂医药-阿斯利康北京创新实验室揭牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2578987562","media":"新京报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578987562?lang=zh_cn&edition=full","pubTime":"2025-10-28 15:32","pubTimestamp":1761636751,"startTime":"0","endTime":"0","summary":"10月25日，和铂医药-阿斯利康创新实验室在北京正式揭牌，和铂医药北京创新中心同步揭牌。据了解，截至目前，和铂医药的抗体技术平台已与阿斯利康、辉瑞、大冢、艾伯维、莫德纳等多家跨国药企达成合作，累计总金额超百亿美元，并获得阿斯利康溢价入股，以及新加坡政府投资公司（GIC）增持股份至7.05%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510283546756820.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510283546756820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","LU0109394709.USD","BK4568","BK1574","BK4585","LU2417539215.USD","LU2456880835.USD","AZN","LU0320765992.SGD","BK1583","LU2462157665.USD","BK4007","LU2236285917.USD","02142","LU0889565916.HKD","LU1829250122.USD","BK4588"],"gpt_icon":0},{"id":"2578662033","title":"和铂医药-B(02142.HK)涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578662033","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578662033?lang=zh_cn&edition=full","pubTime":"2025-10-27 10:06","pubTimestamp":1761530813,"startTime":"0","endTime":"0","summary":"每经AI快讯，和铂医药-B(02142.HK)涨超6%，截至发稿，涨6.35%，报13.23港元，成交额993.94万港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202510273545035794.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202510273545035794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1574","02142","BK1583"],"gpt_icon":0},{"id":"2578662588","title":"港股异动 | 和铂医药-B(02142)涨超6% 与阿斯利康进一步深化合作 AI干湿实验室平台即将正式投入使用","url":"https://stock-news.laohu8.com/highlight/detail?id=2578662588","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578662588?lang=zh_cn&edition=full","pubTime":"2025-10-27 09:51","pubTimestamp":1761529911,"startTime":"0","endTime":"0","summary":"据介绍，今年3月，和铂医药与阿斯利康达成全球战略合作，共同研发针对免疫性疾病、肿瘤及其他多种疾病的新一代多特异性抗体疗法，并在北京建设创新实验室，推动前沿科研落地。经过数月筹备，该创新实验室全面就绪，和铂医药抗体药物创新开发平台与AI干湿实验室平台已完成搭建，即将正式投入使用，助力多领域新一代治疗性抗体研发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1360185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1829250122.USD","BK1574","BK4007","BK1583","LU0109394709.USD","LU2236285917.USD","LU2417539215.USD","BK4585","LU2456880835.USD","LU0889565916.HKD","BK1161","AZN","BK4588","BK4568","02142","LU2462157665.USD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2578618447","title":"和铂医药-B盘中异动 早盘急速上涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578618447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578618447?lang=zh_cn&edition=full","pubTime":"2025-10-27 09:34","pubTimestamp":1761528864,"startTime":"0","endTime":"0","summary":"2025年10月27日早盘09时34分，和铂医药-B股票出现异动，股价快速拉升5.23%。截至发稿，该股报13.090港元/股，成交量17.6万股，换手率0.02%，振幅4.50%。和铂医药-B股票所在的生物技术行业中，整体涨幅为2.67%。其相关个股中，药明合联、昭衍新药、药明康德涨幅较大，振幅较大的相关个股有三叶草生物-B、药捷安康-B、歌礼制药-B，振幅分别为6.80%、6.65%、5.81%。该公司的产品包括HBM9161, HBM4003, HBM7008 and HBM1020。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027093424a6cf994e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027093424a6cf994e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","02142","BK1583","BK1161"],"gpt_icon":0},{"id":"2577304885","title":"和铂医药-B(02142)10月23日斥资247.26万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2577304885","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577304885?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:17","pubTimestamp":1761221821,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和铂医药-B(02142)发布公告，于2025年10月23日，该公司斥资247.26万港元回购20万股股份，每股回购价格为12.14-12.48港元。\r\n\r\n　　\r\n\r\n　　【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251023/31731638.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","BK1574","02142","BK1161"],"gpt_icon":0},{"id":"2577254554","title":"每日卖空追踪 | 和铂医药-B 10月23日卖空量成交35.6万股，卖空比例为5.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577254554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577254554?lang=zh_cn&edition=full","pubTime":"2025-10-23 16:30","pubTimestamp":1761208226,"startTime":"0","endTime":"0","summary":"和铂医药-B北京时间10月23日，跌4.32%，卖空量成交35.6万股，较上一交易日减少53.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023163322a6c9a24d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251023163322a6c9a24d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"2577544965","title":"和铂医药公布 CTLA-4 联合 PD1 治疗结直肠癌最新临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=2577544965","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577544965?lang=zh_cn&edition=full","pubTime":"2025-10-23 12:00","pubTimestamp":1761192000,"startTime":"0","endTime":"0","summary":"10 月 23 日，和铂医药公布了新一代全人源仅重链抗 CTLA-4 抗体普鲁苏拜单抗联合替雷利珠单抗治疗微卫星稳定型转移性结直肠癌的 II 期临床积极数据。在这一难治人群中，联合疗法展现出令人鼓舞的抗肿瘤活性及可控的安全性。这项多中心、开放标签的 II 期研究共纳入24 例既往接受过多线治疗的非肝转移性 MSS mCRC 患者。主要疗效终点为基于 RECIST 1.1 标准的客观缓解率。结果显示，疗效方面，在 23 例可评估患者中，联合治疗展现出良好的抗肿瘤活性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102312362294d8f652&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102312362294d8f652&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","BK1574","BK1161","02142"],"gpt_icon":0},{"id":"2577341143","title":"智通港股回购统计|10月23日","url":"https://stock-news.laohu8.com/highlight/detail?id=2577341143","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577341143?lang=zh_cn&edition=full","pubTime":"2025-10-23 09:10","pubTimestamp":1761181802,"startTime":"0","endTime":"0","summary":"其中，回购金额最大的为瑞声科技，回购数量30.00 万，回购金额1190.98 万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1358499.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02273","01583","01672","01986","02000","LU0672654166.SGD","00345","LU0320764755.SGD","01167","08128","02598","01762","01373","09959","08188","06098","01497","BK1161","BK1520","HK0000306685.HKD","02158","LU1224709979.USD","LU0385154629.USD","01681","BK1506","01328","00418","00947","BK1608","02319","BK1149","02190","LU0823426480.USD","02416","BK1128","IE00B97KM107.HKD","00103","02142","BK1095","02018","06868","BK1104","08149","02306","BK1575","SG9999002828.SGD","02869","LU0359202008.SGD","00777","03669"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0174},{"period":"1month","weight":-0.1566},{"period":"3month","weight":0.2481},{"period":"6month","weight":0.4438},{"period":"1year","weight":10.1897},{"period":"ytd","weight":5.9785}],"compareEarnings":[{"period":"1week","weight":0.0077},{"period":"1month","weight":-0.0175},{"period":"3month","weight":0.0655},{"period":"6month","weight":0.1582},{"period":"1year","weight":0.2896},{"period":"ytd","weight":0.3203}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"和铂医药控股有限公司是一家主要从事肿瘤免疫学及免疫性疾病领域的创新疗法开发业务的投资控股公司。该公司的产品包括HBM9161, HBM4003, HBM7008 and HBM1020。其中，巴托利单抗（HBM9161）主要用于免疫性血小板减少症、甲状腺相关性眼病、重症肌无力、视神经脊髓炎谱系疾病等. 特那西普（HBM9036）主要用于干眼病。此外，该公司还研究和开发肿瘤免疫产品管线，包括内部开发的新一代肿瘤免疫资产，针对治疗免疫沙漠型、免疫排斥型及炎症型肿瘤。该公司拥有Harbour Mice平台，该平台能够产生经典的双重链双轻链（H2L2）形式及仅重链（HCAb）形式的全人源单克隆抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.104328},{"month":2,"riseRate":0.2,"avgChangeRate":-0.004171},{"month":3,"riseRate":0.4,"avgChangeRate":0.046232},{"month":4,"riseRate":0.4,"avgChangeRate":0.013317},{"month":5,"riseRate":0.6,"avgChangeRate":0.040454},{"month":6,"riseRate":0.2,"avgChangeRate":-0.066065},{"month":7,"riseRate":0.4,"avgChangeRate":0.030357},{"month":8,"riseRate":0.2,"avgChangeRate":0.005624},{"month":9,"riseRate":0.4,"avgChangeRate":-0.065735},{"month":10,"riseRate":0,"avgChangeRate":-0.180686},{"month":11,"riseRate":0.6,"avgChangeRate":0.250466},{"month":12,"riseRate":0.75,"avgChangeRate":0.358142}],"exchange":"SEHK","name":"和铂医药-B","nameEN":"HBM HOLDINGS-B"},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.5","shortVersion":"4.35.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和铂医药-B,02142,和铂医药-B股票,和铂医药-B股票老虎,和铂医药-B股票老虎国际,和铂医药-B行情,和铂医药-B股票行情,和铂医药-B股价,和铂医药-B股市,和铂医药-B股票价格,和铂医药-B股票交易,和铂医药-B股票购买,和铂医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和铂医药-B(02142)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和铂医药-B(02142)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}